World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
56
Citations
11830
World Ranking
3718
National Ranking
24

Bjarne Bogen publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Bjarne Bogen sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 252 publications — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Bjarne Bogen D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Bjarne Bogen sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 56 D-Index — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Bjarne Bogen is a researcher affiliated with Oslo University Hospital in Norway. Their work primarily spans the fields of Immunology and Microbiology as well as Medicine, with a notable emphasis on Immunology.

The scientist's research includes contributions to several subfields such as Immunology, Molecular Biology, Oncology, Epidemiology, and Radiology, Nuclear Medicine and Imaging. Their research topics frequently involve Immunotherapy and Immune Responses, Immune Cell Function and Interaction, T-cell and B-cell Immunology, Influenza Virus Research Studies, Multiple Myeloma Research and Treatments, vaccines and immunoinformatics approaches, and Monoclonal and Polyclonal Antibodies Research.

Bogen has authored multiple research papers in prominent scientific journals. Some notable recent papers include:

  • "Targeting Antigens to Different Receptors on Conventional Type 1 Dendritic Cells Impacts the Immune Response" (2020, The Journal of Immunology)
  • "Antigen bivalency of antigen-presenting cell-targeted vaccines increases B cell responses" (2022, Cell Reports)
  • "Neuraminidase delivered as an APC-targeted DNA vaccine induces protective antibodies against influenza" (2023, Molecular Therapy)
  • "ARHGAP45 controls naïve T- and B-cell entry into lymph nodes and T-cell progenitor thymus seeding" (2021, EMBO Reports)
  • "Trimeric, APC-Targeted Subunit Vaccines Protect Mice against Seasonal and Pandemic Influenza" (2023, Journal of Virology)

The scientist frequently publishes in venues such as Frontiers in Immunology, Blood, and the Journal for ImmunoTherapy of Cancer. Other publication venues include The Journal of Immunology and Cell Reports.

Bogen collaborates with a number of co-authors with whom they have published multiple papers. Frequent collaborators include Even Fossum, Ranveig Braathen, Demo Yemane Tesfaye, Sonja Bobic, and Arnar Gudjonsson.

Best Publications

  • Unsupervised High-Dimensional Analysis Aligns Dendritic Cells across Tissues and Species.

    Martin Guilliams;Martin Guilliams;Charles-Antoine Dutertre;Charles-Antoine Dutertre;Charlotte L. Scott;Naomi McGovern

  • Endocytic pathways regulate Toll‐like receptor 4 signaling and link innate and adaptive immunity

    Harald Husebye;Øyvind Halaas;Harald Stenmark;Harald Stenmark;Gro Tunheim

  • Primary antitumor immune response mediated by CD4+ T cells.

    Alexandre Corthay;Dag K. Skovseth;Katrin U. Lundin;Egil Røsjø

  • The Inhibitor of Death Receptor Signaling, Flice-Inhibitory Protein Defines a New Class of Tumor Progression Factors

    Mounira Djerbi;Valentina Screpanti;Anca Irinel Catrina;Bjarne Bogen

  • Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer

    Ole Audun Werner Haabeth;Kristina Berg Lorvik;Clara Hammarström;Ian M. Donaldson

  • MHC class II-restricted presentation of intracellular antigen.

    Siegfried Weiss;Bjarne Bogen

  • B-lymphoma cells process and present their endogenous immunoglobulin to major histocompatibility complex-restricted T cells.

    Siegfried Weiss;Bjarne Bogen

  • How Do CD4+ T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?

    Ole Audun Haabeth;Anders Tveita;Marte Hotvedt Fauskanger;Fredrik Hellem Schjesvold

  • Cutting edge: expression of XCR1 defines mouse lymphoid-tissue resident and migratory dendritic cells of the CD8α+ type.

    Karine Crozat;Samira Tamoutounour;Thien-Phong Vu Manh;Even Fossum

  • Peripheral T cell tolerance as a tumor escape mechanism: deletion of CD4+ T cells specific for a monoclonal immunoglobulin idiotype secreted by a plasmacytoma.

    Bjarne Bogen

  • Broad and Largely Concordant Molecular Changes Characterize Tolerogenic and Immunogenic Dendritic Cell Maturation in Thymus and Periphery

    Laurence Ardouin;Hervé Luche;Rabie Chelbi;Sabrina Carpentier

  • Idiotope-specific T cell clones that recognize syngeneic immunoglobulin fragments in the context of class II molecules

    Unknown

  • Human XCR1 + Dendritic Cells Derived In Vitro from CD34 + Progenitors Closely Resemble Blood Dendritic Cells, Including Their Adjuvant Responsiveness, Contrary to Monocyte-Derived Dendritic Cells

    Sreekumar Balan;Vincent Ollion;Nicholas Colletti;Rabie Chelbi

  • Naive Idiotype-Specific CD4^+ T Cells and Immunosurveillance of B-Cell Tumors

    Grete Fossum Lauritzsen;Siegfried Weiss;Zlatko Dembic;Bjarne Bogen

  • Adoptive Transfer of Tumor-Specific Th2 Cells Eradicates Tumors by Triggering an In Situ Inflammatory Immune Response.

    Kristina Berg Lorvik;Clara Hammarström;Marte Fauskanger;Ole Audun Werner Haabeth

  • Chronic lymphocytic leukemia cells are activated and proliferate in response to specific T helper cells.

    Audun Os;Simone Bürgler;Anna Parente Ribes;Anna Parente Ribes;Ane Funderud;Ane Funderud

  • Vaccine molecules targeting Xcr1 on cross-presenting DCs induce protective CD8+ T-cell responses against influenza virus.

    Even Fossum;Gunnveig Grødeland;Dorothea Terhorst;Anders A. Tveita

  • Clonal deletion of specific thymocytes by an immunoglobulin idiotype.

    B. Bogen;Z. Dembic;S. Weiss

  • The role of idiotype-specific, CD4+ T cells in tumor resistance against major histocompatibility complex class II molecule negative plasmacytoma cells.

    G.F. Lauritzsen;B. Bogen

  • DNA Vaccines Increase Immunogenicity of Idiotypic Tumor Antigen by Targeting Novel Fusion Proteins to Antigen-Presenting Cells

    Agnete B. Fredriksen;Inger Sandlie;Bjarne Bogen

  • Minimum length of an idiotypic peptide and a model for its binding to a major histocompatibility complex class II molecule.

    B. Bogen;J. D. Lambris

  • Cutting Edge: Link Between Innate and Adaptive Immunity: Toll-Like Receptor 2 Internalizes Antigen for Presentation to CD4+ T Cells and Could Be an Efficient Vaccine Target

    Karoline W. Schjetne;Keith M. Thompson;Nadra Nilsen;Trude H. Flo

Frequent Co-Authors

Inger Sandlie
Inger Sandlie University of Oslo
Zlatko Dembic
Zlatko Dembic University of Oslo
Bernard Malissen
Bernard Malissen Aix-Marseille University
Sandrine Henri
Sandrine Henri Centre d’Immunologie de Marseille-Luminy
Marc Dalod
Marc Dalod Centre d’Immunologie de Marseille-Luminy
Terje E. Michaelsen
Terje E. Michaelsen University of Oslo
Siegfried Weiss
Siegfried Weiss Helmholtz Centre for Infection Research
Charles-Antoine Dutertre
Charles-Antoine Dutertre Institut Gustave Roussy
Guttorm Haraldsen
Guttorm Haraldsen Oslo University Hospital
Rudolf A. Manz
Rudolf A. Manz University of Lübeck

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Nursing remains a popular choice, with many students seeking accelerated paths. If you’re looking to start quickly, consider accelerated nursing programs near me, which offer faster routes into nursing professions while maintaining quality education.

Entry-level nursing roles also provide a solid foundation for advanced immunology careers. Programs focused on practical nursing are becoming increasingly accessible. Researching easy lpn programs to get into can be a great way to begin a healthcare career with minimal barriers to admission.

For professionals aiming to deepen their clinical impact, nurse practitioner degrees are valuable. Many institutions feature nurse practitioner programs with easy admission, catering to working nurses and career changers seeking specialization in immunology-related fields.

Specializing further, mental health often overlaps with immunology in patient care. The best online pmhnp programs provide excellent clinical placement rates, making it easier to gain real-world experience while studying. These programs can prepare graduates for focused psychiatric and mental health nursing careers.

Best Scientists Citing Bjarne Bogen

Trending Scientists

Recently Published Articles